{"entity":{"id":"nct02485652","kind":"trial","name":"Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung","aka":[],"tldr":"A phase 2 trial of Olmutinib in Non-small-cell lung cancer, run by Hanmi Pharmaceutical Company Limited, recorded as terminated on the registry.","summary":"Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung is a phase 2 interventional study registered as NCT02485652 by Hanmi Pharmaceutical Company Limited, with 162 participants recorded, started 2015-08-31 and due to reach its primary completion in 2020-12-08. Interventions recorded: HM61713. Conditions recorded: Non Small Cell Lung Cancer.\n\nLinked to the drug Olmutinib because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02485652","url":"https://clinicaltrials.gov/study/NCT02485652"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["olmutinib"],"companies":["hanmi-pharmaceutical"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02485652","phase":"2","setting":"A Single Arm, Open-label, Phase 2 Study Evaluating the Efficacy, Safety and PK of HM61713 in Patients With T790M-positive NSCLC After Treatment With an Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor","sponsor":"Hanmi Pharmaceutical Company Limited","enrolled":162,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02485652/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"olmutinib","kind":"drug","name":"Olmutinib","route":"/drugs/olmutinib/"}],"company":[{"id":"hanmi-pharmaceutical","kind":"company","name":"Hanmi Pharmaceutical","route":"/companies/hanmi-pharmaceutical/"}]}}